ATE226594T1 - Peptide abgeleitet aus dem morbillivirus - Google Patents

Peptide abgeleitet aus dem morbillivirus

Info

Publication number
ATE226594T1
ATE226594T1 AT97942832T AT97942832T ATE226594T1 AT E226594 T1 ATE226594 T1 AT E226594T1 AT 97942832 T AT97942832 T AT 97942832T AT 97942832 T AT97942832 T AT 97942832T AT E226594 T1 ATE226594 T1 AT E226594T1
Authority
AT
Austria
Prior art keywords
morbillivirus
peptides
peptides derived
acid sequence
disclosed
Prior art date
Application number
AT97942832T
Other languages
English (en)
Inventor
Claude P Muller
Original Assignee
Claude P Muller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Claude P Muller filed Critical Claude P Muller
Application granted granted Critical
Publication of ATE226594T1 publication Critical patent/ATE226594T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K16/11
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18411Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT97942832T 1996-07-31 1997-07-26 Peptide abgeleitet aus dem morbillivirus ATE226594T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96112341 1996-07-31
PCT/EP1997/004070 WO1998005682A2 (en) 1996-07-31 1997-07-26 Peptides corresponding or imitating at least one antigenic determinant of the hamagglutinin protein of mobillivirus

Publications (1)

Publication Number Publication Date
ATE226594T1 true ATE226594T1 (de) 2002-11-15

Family

ID=8223060

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97942832T ATE226594T1 (de) 1996-07-31 1997-07-26 Peptide abgeleitet aus dem morbillivirus

Country Status (5)

Country Link
EP (1) EP0920449B1 (de)
AT (1) ATE226594T1 (de)
AU (1) AU4452897A (de)
DE (1) DE69716609T2 (de)
WO (1) WO1998005682A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2880043A1 (es) * 2020-05-20 2021-11-23 Fundacion Para El Fomento De La Investig Sanitaria Y Biomedica De La Comunitat Valenciana Fisabio Peptido para uso en la prevencion y/o tratamiento de una enfermedad causada por un virus que afecta a las vias respiratorias

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3045581B2 (ja) * 1991-10-14 2000-05-29 社団法人北里研究所 麻疹ワクチンウイルス株同定方法

Also Published As

Publication number Publication date
EP0920449A2 (de) 1999-06-09
EP0920449B1 (de) 2002-10-23
DE69716609D1 (de) 2002-11-28
AU4452897A (en) 1998-02-25
WO1998005682A2 (en) 1998-02-12
DE69716609T2 (de) 2003-07-03
WO1998005682A3 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
NZ507378A (en) Fusion proteins of mycobacterium tuberculosis antigens and their uses
ATE366313T1 (de) Antigene peptide aus neisseria
GB9215780D0 (en) Peptide compounds
HU9500270D0 (en) Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them
BR9906927A (pt) Proteìnas de neisseria meningitidis
CA2297786A1 (en) New immunoprotective influenza antigen and its use in vaccination
ATE70717T1 (de) Vermehrung der antigenimmunogenizitaet.
WO1995029193A3 (en) Melanoma antigens
DE69636453D1 (de) Modulation der aktivität des cholesteryl-ester-transfer-proteins (cetp)
ATE298798T1 (de) Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin
WO1997026784B1 (en) Induction of immune response against desired determinants
CA2242878A1 (en) Induction of immune response against desired determinants
DE69836744D1 (de) Gruppe a streptokokken-impfstoff
RU95109910A (ru) Бактериоцины, нуклеотидная последовательность, сигнальный пептид, штамм, способ получения, применение бактериоцина, применение нуклеотидной последовательности
DE69716609D1 (de) Peptide abgeleitet aus dem morbillivirus
IL109790A0 (en) Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
NO992158L (no) Nukleinsyre- og aminosyresekvenser forbundet med Heliobacter Pylori og vaksinepreparater av disse.
DK0762895T3 (da) Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
CA2158024A1 (en) A mycoplasma gallisepticum antigen, dna encoding the antigen, recombinant vector bearing the dna and recombinant virus utilizing the recombinant vector as well as use thereof
CA2128407A1 (en) Synthetic peptides for a rubella vaccine
WO2000006706A3 (en) Map kinase phosphatase mutant
PE20010239A1 (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos
WO2000047227A3 (en) Mycobacterium tuberculosis, immunization
IT1277057B1 (it) Peptidi antigenici migliorati

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties